376 related articles for article (PubMed ID: 16537810)
1. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo.
Warger T; Osterloh P; Rechtsteiner G; Fassbender M; Heib V; Schmid B; Schmitt E; Schild H; Radsak MP
Blood; 2006 Jul; 108(2):544-50. PubMed ID: 16537810
[TBL] [Abstract][Full Text] [Related]
2. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
[TBL] [Abstract][Full Text] [Related]
3. Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer.
Hong X; Dong T; Hu J; Yi T; Li W; Zhang Z; Lin S; Niu W
Int J Colorectal Dis; 2013 Jan; 28(1):25-33. PubMed ID: 22777000
[TBL] [Abstract][Full Text] [Related]
4. A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways.
Xie G; Welte T; Wang J; Whiteman MC; Wicker JA; Saxena V; Cong Y; Barrett AD; Wang T
Vaccine; 2013 Aug; 31(38):4143-51. PubMed ID: 23845800
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin-induced maturation of MyD88-deficient dendritic cells.
Kaisho T; Takeuchi O; Kawai T; Hoshino K; Akira S
J Immunol; 2001 May; 166(9):5688-94. PubMed ID: 11313410
[TBL] [Abstract][Full Text] [Related]
7. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells.
Dillon S; Agrawal A; Van Dyke T; Landreth G; McCauley L; Koh A; Maliszewski C; Akira S; Pulendran B
J Immunol; 2004 Apr; 172(8):4733-43. PubMed ID: 15067049
[TBL] [Abstract][Full Text] [Related]
8. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses.
Heer AK; Shamshiev A; Donda A; Uematsu S; Akira S; Kopf M; Marsland BJ
J Immunol; 2007 Feb; 178(4):2182-91. PubMed ID: 17277123
[TBL] [Abstract][Full Text] [Related]
9. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors as adjuvant receptors.
Kaisho T; Akira S
Biochim Biophys Acta; 2002 Feb; 1589(1):1-13. PubMed ID: 11909637
[TBL] [Abstract][Full Text] [Related]
11. Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-κB signaling pathway.
Hu Y; Cong X; Chen L; Qi J; Wu X; Zhou M; Yoo D; Li F; Sun W; Wu J; Zhao X; Chen Z; Yu J; Du Y; Wang J
Sci Rep; 2016 Apr; 6():23977. PubMed ID: 27046485
[TBL] [Abstract][Full Text] [Related]
12. TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses.
López CB; Moltedo B; Alexopoulou L; Bonifaz L; Flavell RA; Moran TM
J Immunol; 2004 Dec; 173(11):6882-9. PubMed ID: 15557183
[TBL] [Abstract][Full Text] [Related]
13. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
[TBL] [Abstract][Full Text] [Related]
14. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.
Datta SK; Redecke V; Prilliman KR; Takabayashi K; Corr M; Tallant T; DiDonato J; Dziarski R; Akira S; Schoenberger SP; Raz E
J Immunol; 2003 Apr; 170(8):4102-10. PubMed ID: 12682240
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.
Kaisho T; Hoshino K; Iwabe T; Takeuchi O; Yasui T; Akira S
Int Immunol; 2002 Jul; 14(7):695-700. PubMed ID: 12096028
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
17. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
[TBL] [Abstract][Full Text] [Related]
18. Regulation of dendritic cell function through Toll-like receptors.
Kaisho T; Akira S
Curr Mol Med; 2003 Jun; 3(4):373-85. PubMed ID: 12776992
[TBL] [Abstract][Full Text] [Related]
19. Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection.
Lopez PA; Denny M; Hartmann AK; Alflen A; Probst HC; von Stebut E; Tenzer S; Schild H; Stassen M; Langguth P; Radsak MP
J Dermatol Sci; 2017 Sep; 87(3):252-259. PubMed ID: 28655469
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines.
Zhu Q; Egelston C; Vivekanandhan A; Uematsu S; Akira S; Klinman DM; Belyakov IM; Berzofsky JA
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16260-5. PubMed ID: 18845682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]